Stephane Budel and DeciBio post a four-page summary of some of their recent research on the moving l ine between tools and clinical diagnostics. Find their post and PDF here.
Writing,
Life sciences research tools (LSRT) companies are pivoting hard toward clinical and translational value pools:
- Illumina: ~60% of consumables now clinical...
- 10x Genomics: launching a CLIA lab...
- [more examples]
Adding, “clinicalization” requires a significant business model transformation. Reimbursement, quality systems, go-to-market, partnerships… it all changes...
